Examiner Clark Amy L (SPE)

1628-CLARK-AMY-L

Employment Information

Art Unit:1628 — Drug, bio-affecting and body treating compositions
Group:1620 — Biomedicinal Chemistry
Classes: 424 — Drug, bio-affecting and body treating compositions
514 — Drug, bio-affecting and body treating compositions
552 — Organic compounds -- part of the class 532-570 series
540 — Organic compounds -- part of the class 532-570 series
Phone:(571) 272-1310
Email:amy.clark@uspto.gov
Location:VA 22314
Title:Supvy Pat Examnr Gen Chem
Service:21 years
Grade:GS-15

Grant Rate and Difficulty Ranking

87
3-Year Grant rate: 38% over 240 cases
Difficulty: Very Hard
Difficulty Percentile: 87th

With Examiner Clark (SPE), you have a 38% chance of getting an issued patent by 3 years after the first office action. Examiner Clark (SPE) is a very hard examiner and in the 87th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Clark (SPE), where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1628

Examiner Clark (SPE)'s grant rate is lower than that of Art Unit 1628 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Clark (SPE) 2.3
Art Unit 1628 1.7

Interview Benefit

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Recent Dispositions

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Appeal History

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.

Loading...